Medicinal Cannabis (Clinical Trial): Avecho (ASX:AVE) cleared a key checkpoint in its pivotal cannabidiol insomnia trial, with an independent monitoring board recommending the study continue at the originally planned size and restarting final-stage recruitment. Medicinal Cannabis (Corporate Integration): Little Green Pharma (ASX:LGP) completed its Cannatrek merger, creating a larger group with expanded cultivation/manufacturing and clinic operations across Australia and Europe—now the market watches integration and cost synergies. Medicinal Cannabis (Regulatory Pathway): Neurotech (ASX:NTI) is pushing a low-THC, standardized cannabinoid formulation through conventional pharmaceutical development, with a US clearance opening a parallel dosing study to build a single evidence package. Medicinal Cannabis (Clinic Expansion): Emyria (ASX:EMD) extended its Empax clinic network across mainland states, including a new western Sydney site, supported by a private health insurance reimbursement pathway. Industry & Safety (Workforce Training): Oklahoma’s cannabis sector is spotlighting safety after a fatal THC extraction blast in Sand Springs, with Tulsa Community College partnering with Green Flower on online workforce certificates covering cultivation, product development, retail, medical use, and compliance. Policy & Access (State/Local): Alabama opened a new medical cannabis dispensary in Talladega, expanding access for qualifying patients under doctor oversight. Enforcement & Seizures: Meghalaya Police reported multiple heroin busts, including a high-value recovery that they say shows a shift from transit to consumer-market dynamics. Retail/Operations (Disclosure): Herbal Wellness Center’s owner says it’s cooperating with an investigation after a temporary closure tied to missing information. Hemp & Culture: A New York “Farm to Fabric” hemp textile and fashion symposium is set to spotlight hemp’s journey from field to fiber and design.